A research study for patients who have been diagnosed with multiple sclerosis

  • STATUS
    Recruiting
Updated on 23 November 2020

Summary

A research study for patients who have been diagnosed with multiple sclerosis

Description

The purpose of this study is to monitor the safety profile of an approved medication called fingolimod compared to other approved medications for the treatment of multiple sclerosis.

This is a mulitnational study which will include approximately 2400 patients. It is an observational study of patients who will be starting treatment with fingolimod or other approved multiple sclerosis medications or have started treatment within the past 6 months.

There is no fixed duration of participation for each subject in this study. Almost all visits will be standard routine visits scheduled by your treating physician. This is not a study to test an investigation medication, but rather an observational study to gather additional information on treatments that are already approved. If you agree to participate in this study, you will provide Informed Consent after your study doctor answers all of your questions.

Details
Condition Multiple Sclerosis
Clinical Study IdentifierTX138174
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 10 yrs and 80 yrs?
Gender: Male or Female
Do you have Multiple Sclerosis?
Diagnosis of multiple sclereosis
Will be starting or has started within the past 6 months an approved treatment for multiple sclerosis
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note